iShares Biotechnology ETF (NASDAQ:IBB) Shares Sold by SP Asset Management LLC

SP Asset Management LLC cut its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 4.7% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 52,944 shares of the financial services provider’s stock after selling 2,623 shares during the period. SP Asset Management LLC’s holdings in iShares Biotechnology ETF were worth $7,267,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently bought and sold shares of the company. Future Financial Wealth Managment LLC purchased a new stake in shares of iShares Biotechnology ETF during the 1st quarter valued at approximately $27,000. Bbjs Financial Advisors LLC acquired a new stake in iShares Biotechnology ETF during the second quarter worth $31,000. Pacifica Partners Inc. raised its position in iShares Biotechnology ETF by 118.2% in the first quarter. Pacifica Partners Inc. now owns 240 shares of the financial services provider’s stock valued at $33,000 after purchasing an additional 130 shares during the period. Crewe Advisors LLC lifted its stake in shares of iShares Biotechnology ETF by 42.9% in the 4th quarter. Crewe Advisors LLC now owns 260 shares of the financial services provider’s stock valued at $35,000 after purchasing an additional 78 shares during the last quarter. Finally, YHB Investment Advisors Inc. acquired a new position in shares of iShares Biotechnology ETF in the 1st quarter valued at $37,000. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Price Performance

Shares of NASDAQ:IBB opened at $144.92 on Wednesday. iShares Biotechnology ETF has a 12-month low of $111.83 and a 12-month high of $150.17. The business has a 50-day moving average price of $144.45 and a 200 day moving average price of $138.13.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.